申请人:BASF Aktiengesellschaft
公开号:US06159981A1
公开(公告)日:2000-12-12
3-Substituted 3,4,5,6,7,8-hexahydropyrido [3',4':4,5]-thieno[2,3-d]pyrimidine derivatives of the formula I ##STR1## where R.sup.1 is a hydrogen atom, a C.sub.1 -C.sub.4 -alkyl group, an acetyl group, a phenylalkyl C.sub.1 -C.sub.4 radical, the aromatic system being unsubstituted or substituted by halogen, C.sub.1 -C.sub.4 -alkyl, trifluoromethyl, hydroxyl, C.sub.1 -C.sub.4 -alkoxy, amino, cyano or nitro groups, or is a phenylalkanone radical, it being possible for the phenyl group to be substituted by halogen, R.sup.2 is a phenyl, pyridyl, pyrimidinyl or pyrazinyl group which is unsubstituted or mono- or disubstituted by halogen atoms, C.sub.1 -C.sub.4 -alkyl, trifluoromethyl, trifluoromethoxy, hydroxyl, C.sub.1 -C.sub.4 -alkoxy, amino, monomethylamino, dimethylamino, cyano or nitro groups and which may be fused to a benzene nucleus which can be unsubstituted or mono- or disubstituted by halogen atoms, C.sub.1 -C.sub.4 -alkyl, hydroxyl, trifluoromethyl, C.sub.1 -C.sub.4 -alkoxy, amino, cyano or nitro groups and may contain 1 nitrogen atom, or to a 5- or 6-membered ring which may contain 1-2 oxygen atoms, A is NH or an oxygen atom, Y is CH.sub.2, CH.sub.2 --CH.sub.2, CH.sub.2 --CH.sub.2 --CH.sub.2 or CH.sub.2 --CH, Z is a nitrogen atom, carbon atom or CH, it also being possible for the linkage between Y and Z to be a double bond, and n is 2, 3 or 4, and the physiologically tolerated salts thereof.
3-取代的3,4,5,6,7,8-六氢吡啶[3',4':4,5]-噻吩[2,3-d]嘧啶衍生物的结构式为I ##STR1## 其中R.sup.1是氢原子,C.sub.1-C.sub.4-烷基,乙酰基,苯基C.sub.1-C.sub.4基团,芳香环未取代或由卤素,C.sub.1-C.sub.4-烷基,三氟甲基,羟基,C.sub.1-C.sub.4-烷氧基,氨基,氰基或硝基取代,或是苯基酮基团,苯基可能被卤素取代;R.sup.2是未取代或单取代或双取代的苯基,吡啶基,嘧啶基或吡嗪基团,取代基为卤素原子,C.sub.1-C.sub.4-烷基,三氟甲基,三氟甲氧基,羟基,C.sub.1-C.sub.4-烷氧基,氨基,单甲基氨基,二甲基氨基,氰基或硝基,可能与苯环融合,苯环未取代或单取代或双取代,可能含有1个氮原子,或融合到含有1-2个氧原子的5-或6-成员环中;A为NH或氧原子,Y为CH.sub.2,CH.sub.2--CH.sub.2,CH.sub.2--CH.sub.2--CH.sub.2或CH.sub.2--CH,Z为氮原子,碳原子或CH,Y和Z之间的连接也可能是双键,n为2、3或4,并且其生理耐受的盐。